VTGN logo
VTGN NASDAQ US

Vistagen Therapeutics, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Oct 2010
$0.59
▼ $-0.01 (-1.67%)
Vol 329K
4
Quality Score
fail
Mkt Cap
$26.1M
ROE
-71.4%
Margin
-6603.4%
D/E
0.99
Beta
0.31
52W
$1–$5

Wall Street Consensus

10 analysts · Apr 2026
0
Strong Buy
0
Buy
7
Hold
1
Sell
2
Strong Sell
0.0%
Buy Rating

Price Chart

Similar Stocks

CYCN
Cyclerion Therapeutics Inc
$5.0M
NEUP
Neuphoria Therapeutics Inc
$20.9M
LGVN
Longeveron Inc
$10.8M
SKYE
Skye Bioscience Inc
$24.0M
SNTI
Senti Biosciences Inc
$27.3M
MRKR
Marker Therapeutics Inc
$24.8M
CRIS
Curis Inc
$12.8M
TPST
Tempest Therapeutics Inc
$14.1M

Earnings

Beat rate: 75.0%
Quarter EPS Est EPS Act Surprise
Dec 2025 $-0.50 $-0.45 +$0.05
Sep 2025 $-0.49 $-0.54 $-0.05
Jun 2025 $-0.48 $-0.47 +$0.01
Mar 2025 $-0.51 $-0.43 +$0.07

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -54.8% -48.1% -54.8% -54.8% -54.8% -71.4%
P/E (TTM) — — — — — —
Net Margin -6186.5% -6774.2% -6375.9% -6375.9% -6375.9% -6603.4%
Gross Margin — — — — — —
D/E Ratio 1.64 0.00 1.64 1.64 1.64 0.99
Current Ratio 5.98 6.51 5.98 5.98 5.98 5.79

Key Ratios

ROA (TTM)
-60.2%
P/S (TTM)
35.52
P/B
1.0
EPS (TTM)
$-1.47
CF/Share
$-4.52
Rev Growth 3Y
-24.1%
52W High
$5.14
52W Low
$0.68
$0.68 52-Week Range $5.14

How does VTGN compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

VTGN AAPG ABEO ABOS ABP

VTGN valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
35.5
▲ 176% above peers (12.9)
vs Peers
vs Industry
Pricier
P/B ratio
1.0
▼ 58% below peers (2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

VTGN profitability vs Biotechnology peers

ROE
-71.4%
▼ 6% below peers (-67.3%)
vs Peers
vs Industry
In line
Net margin
-6603.4%
▼ 2203% below peers (-286.8%)
vs Peers
vs Industry
Weak
Gross margin
—
▼ 0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-60.2%
▼ 29% below peers (-46.7%)
vs Peers
vs Industry
Weak

VTGN financial health vs Biotechnology peers

D/E ratio
1.0
▼ 0% below peers (0.0)
vs Peers
vs Industry
In line
Current ratio
5.8
▲ 30% above peers (4.4)
vs Peers
vs Industry
Below avg
Beta
0.3
▼ 68% below peers (1.0)
vs Peers
vs Industry
More volatile

VTGN fundamentals radar

VTGN Peer median Industry

VTGN profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

VTGN vs peers: key metrics

Latest News

No related news yet